Press Releases

REDWOOD CITY, Calif., Jan. 7, 2020 /PRNewswire/ -- Revolution Medicines, Inc., a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced that preliminary data from the company's Phase 1 clinical trial (RMC-4630-01) of RMC-4630 will be presented at the 6th

CARLSBAD, Calif., Jan. 7, 2020 /PRNewswire/ -- The neurological franchise of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, continued to shape the scientific and therapeutic landscape of the global biotechnology industry in 2019. By any metric, it was a remarkable year; from advancing potential breakthrough therapies in the clin

NEW YORK, Jan. 7, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") announced today that Sandesh Seth, Actinium's Chairman and CEO, will present at the 2020 Biotech Showcase™ being held on January 13-15. The conference will be at the Hilton San Franci

NEW YORK, Jan. 7, 2020 /PRNewswire/ -- Ride Health, providing smarter transportation for every patient need, announced the closing of a $6.2 million seed funding

NEWARK, Calif., Jan. 7, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the achievement of a research milestone under its worldwide license and research collaboration agreement with Janssen Biotech, Inc. ("Janssen"), for co-development activities with affiliate Janssen Research & Development, LLC, and commercialization of oral,

KINGS PARK, N.Y., Jan. 7, 2020 /PRNewswire/ -- New York-based massage and pain relief technology company, truMedic, which earned critical acclaim for its Insta

JOHNSON CITY, N.Y., Jan. 7, 2020 /PRNewswire/ -- Innovation, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, federal health care, and mail order pharmacy markets, today announced several changes to the company's leadership team. The leadership changes come on the heels of the recent closing of the

CAESAREA, Israel, Jan. 7, 2020 /PRNewswire/ -- Following the additional U.S. Food and Drug Administration (FDA) clearance for its Cryoablation Technology, IceCure Medical Ltd. (TASE: ICCM), an Israeli medical device company, developers of a non-surgical Liquid Nitrogen (LN2) cryoablation technology to destroy benign and cancerous tumors by freezing, plans

TEL AVIV, Israel, Jan. 7, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, received official communication from two jurisdictions, the European Patent Office (EPO) and the Israeli Intellectual Property Office, regarding their intention to grant European Patent Applic

IRVINE, Calif., Jan. 7, 2020 /PRNewswire/ -- Genomic Testing Cooperative, LCA announced that the Medicare Administrative Contractor Palmetto GBA (Mo